Chairman Griffith Delivers Opening Statement at Subcommittee on Health Hearing on Maintaining U.S. Leadership in Biomedical Innovation
July 16, 2026
July 16, 2026
WASHINGTON, July 16 -- Rep. Morgan Griffith, R-Virginia, chairman of the House Energy and Commerce Subcommittee on Health, issued the following opening statement on July 15, 2026, at a hearing entitled "Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development":
* * *
"Today's hearing will examine ways to maintain American leadership in biomedical innovation.
"This hearing is . . .
* * *
"Today's hearing will examine ways to maintain American leadership in biomedical innovation.
"This hearing is . . .